Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease

被引:5
|
作者
Williams, Adam N. [1 ,2 ,3 ]
机构
[1] Bend Mem Clin, Dept Allergy Asthma & Immunol, 815 Southwest Bond St, Bend, OR 97702 USA
[2] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[3] Bend Mem Clin, 815 Southwest Bond St, Bend, OR 97702 USA
关键词
Aspirin-exacerbated respiratory disease; Diagnosis; NSAID hypersensitivity; Chronic rhinosinusitis with nasal polyps; Asthma; Intranasal ketorolac; Oral aspirin challenge; Lysine-aspirin; PERIPHERAL-BLOOD LEUKOCYTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEUKOTRIENE-MODIFIER DRUGS; NASAL PROVOCATION TEST; IN-VITRO DIAGNOSIS; INDUCED ASTHMA; SENSITIVE ASTHMATICS; BASOPHIL ACTIVATION; CYSTEINYL LEUKOTRIENES; LYSINE-ASPIRIN;
D O I
10.1016/j.iac.2016.06.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Aspirin-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). Distinguishing AERD from other forms of chronic sinusitis, asthma, and NSAID reactivity has important clinical implications for management. The clinical history is helpful, but not adequate for confirming the diagnosis of AERD, in most cases. Diagnostic provocation challenge remains the only way to confirm or exclude the diagnosis of AERD. This article discusses the utility of the clinical history and the current evidence regarding measures that optimize the safety of performing diagnostic NSAID provocation challenges.
引用
收藏
页码:657 / +
页数:14
相关论文
共 50 条
  • [41] Aspirin-exacerbated respiratory disease - the Davos concept
    Willer, G.
    Leder, J. C.
    Menz, G.
    ALLERGOLOGIE, 2014, 37 (01) : 20 - 25
  • [42] Inflammatory heterogeneity in aspirin-exacerbated respiratory disease
    Scott, William C.
    Cahill, Katherine N.
    Milne, Ginger L.
    Li, Ping
    Sheng, Quanhu
    Huang, Li Ching
    Dennis, Spencer
    Snyder, Jacob
    Bauer, Ashley M.
    Chandra, Rakesh K.
    Chowdhury, Naweed I.
    Turner, Justin H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (04) : 1318 - +
  • [43] Update on the Management of Aspirin-Exacerbated Respiratory Disease
    Buchheit, Kathleen M.
    Laidlaw, Tanya M.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2016, 8 (04) : 298 - 304
  • [44] Aspirin-Exacerbated Respiratory Disease: Clinical Disease and Diagnosis
    Bochenek, Grazyna
    Nizankowska-Mogilnicka, Ewa
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (02) : 147 - +
  • [45] An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease
    Shaker, Marcus
    Lobb, Ano
    Jenkins, Pamela
    O'Rourke, Daniel
    Takemoto, Steve K.
    Sheth, Salil
    Burroughs, Thomas
    Dykewicz, Mark S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (01) : 81 - 87
  • [46] Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease
    Pitlick, Mitchell M.
    Pongdee, Thanai
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (08): : 2187 - +
  • [47] Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease
    Hill, Jennifer
    Burnett, Trever
    Katial, Rohit
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2016, 36 (04) : 735 - +
  • [48] Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease
    Ban, G. -Y.
    Cho, K.
    Kim, S. -H.
    Yoon, M. K.
    Kim, J. -H.
    Lee, H. Y.
    Shin, Y. S.
    Ye, Y. -M.
    Cho, J. -Y.
    Park, H. -S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (01): : 37 - 47
  • [49] Pancreatitis as a complication of aspirin desensitization for aspirin-exacerbated respiratory disease
    Durrani, Sandy R.
    Kelly, John T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) : 244 - 246
  • [50] Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease
    Mustafa, S. Shahzad
    Vadamalai, Karthik
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (06) : 738 - 739